Fatemeh Aghai-Trommeschlaeger

Monitoring of Dabrafenib and Trametinib in Serum and Self-Sampled Capillary Blood in Patients with BRAFV600-Mutant Melanoma

A. Gesierich, O. Scherf-Clavel, H. Klinker, 2022, Cancers.

A Physiologically-Based Pharmacokinetic Model of Ruxolitinib and Posaconazole to Predict CYP3A4-Mediated Drug–Drug Interaction Frequently Observed in Graft versus Host Disease Patients

Bettina Gerner, O. Scherf-Clavel, H. Klinker, 2022, Pharmaceutics.

Comparison of a newly developed high performance liquid chromatography method with diode array detection to a liquid chromatography tandem mass spectrometry method for the quantification of cabozantinib, dabrafenib, nilotinib and osimertinib in human serum - Application to therapeutic drug monitorin

A. Gesierich, C. Kalogirou, O. Scherf-Clavel, 2022, Clinical biochemistry.

Clinical validation and assessment of feasibility of volumetric absorptive microsampling (VAMS) for monitoring of nilotinib, cabozantinib, dabrafenib, trametinib, and ruxolitinib.

A. Gesierich, C. Kalogirou, O. Scherf-Clavel, 2023, Journal of pharmaceutical and biomedical analysis.